Related Experiment Video
Updated: May 8, 2026
04:13
Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults
Published on: February 8, 2019
Practical experience with the TAG and conformable TAG devices: lessons learned in about 100 cases
1Department of Vascular Surgery and Kidney Transplantation, Nouvel Hôpital Civil, Strasbourg, France.
The Journal of Cardiovascular Surgery
|September 5, 2013
Summary
The Gore TAG thoracic endoprosthesis shows acceptable outcomes for thoracic aortic pathologies. Further research is needed to understand long-term results and define optimal patient groups for this endovascular repair.
Area of Science:
- Cardiovascular Surgery
- Medical Devices
- Vascular Medicine
Background:
- Thoracic aortic pathologies require effective treatment options.
- Endovascular aortic repair (TEVAR) offers a less invasive approach.
- The Gore TAG thoracic endoprosthesis is a device used in TEVAR.
Purpose of the Study:
- To evaluate the 10-year experience with the Gore TAG thoracic endoprosthesis.
- To analyze outcomes of TEVAR for various thoracic aorta pathologies.
Main Methods:
- Systematic retrospective study of prospectively recorded data.
- Analysis of 96 patients undergoing TEVAR with Gore TAG device (2001-2013).
- Inclusion of patient demographics, complications, reinterventions, and survival data.
Main Results:
- Technical success rate was 96.6% with 10.4% 30-day mortality.
- Major adverse events included stroke (8.3%) and spinal cord ischemia (4.2%).
- Two-year survival was 78%; 10.4% required major reintervention.
Conclusions:
- The Gore TAG device demonstrates acceptable operative mortality and major adverse event rates.
- Endovascular repair is effective for diverse thoracic aortic conditions.
- Long-term outcome data is essential for defining ideal patient candidates.
